ApexCut Blade with Automated EM Tracking (187BL4012EM);ApexCut Blade with Automated EM Tracking (187BL4040EM);ApexCut Blade with Automated EM Tracking (187BL4060EM);ApexCut Blade with Automated EM Tracking (187BL2975EM);ApexCut Blade with Automated EM Tracking (187BL3590EM);ApexCut Blade with Automated EM Tracking (187BL4000LEM)
Medtronic Xomed, Inc. · Decision date Sep 4, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 4, 2026 for K262235, submitted by Medtronic Xomed, Inc. of Jacksonville, Florida, and received July 1, 2026. The submission covers the ApexCut™ Blade with Automated EM Tracking in six configurations (187BL4012EM, 187BL4040EM, 187BL4060EM, 187BL2975EM, 187BL3590EM, 187BL4000LEM), a sterile, single-use navigated ENT blade regulated as a stereotaxic instrument under 21 CFR 882.4560, Class II, product code PGW.
The summary names QuadCut® Navigated Blades (K130608, cleared August 7, 2013) as primary predicate and TruDi® Shaver Blade (K221037) as reference precedent only. Listed differences from the predicate include blade geometry, design features, available angles and diameters, handpiece compatibility within the StraightShot™ M Series, packaging and labeled shelf life; the submitter states these are addressed through verification, navigation accuracy, compatibility, sterilization, packaging, shelf-life, biocompatibility, labeling and risk management. SESE is a clearance, not PMA approval. The summary's stated intended use covers tissue and bone removal during nasal or sinus procedures; clinical performance data and current labeling are not in the provided material.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Sep 4, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262235
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Medtronic Xomed, Inc.
- Product code
- PGW
- Decision code
- SESE
- Decision date
- Sep 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ear, Nose, And Throat Stereotaxic Instrument.
- Applicant
- Medtronic Xomed, Inc.
- Product code
- PGW
- FDA device class
- 2
FDA decision timeline
K262235 received
Application receipt date recorded by FDA.
K262235 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Xomed, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- Jacksonville, FL
Sources and methodology
- Original FDA record: K262235
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records